The fund seeks capital appreciation by investing in companies in the United States.
The investment process is designed to highlight companies that are engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.
The process also focuses on companies that benefit significantly from scientific and technological advances in biotechnology.
Additionally, the research team evaluates a company’s financial condition and industry position, as well as market and economic conditions.
Then the manager constructs a diversified portfolio of stocks from a list of companies in the benchmark index favored by the research team and allocates capital based on its conviction level.
The fund has the flexibility to invest in domestic and foreign issuers.
The fund seeks capital appreciation by investing in companies in the United States.
The investment process is designed to highlight companies that are engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.
The process also focuses on companies that benefit significantly from scientific and technological advances in biotechnology.
Additionally, the research team evaluates a company’s financial condition and industry position, as well as market and economic conditions.
Then the manager constructs a diversified portfolio of stocks from a list of companies in the benchmark index favored by the research team and allocates capital based on its conviction level.
The fund has the flexibility to invest in domestic and foreign issuers.
The fund seeks capital appreciation by investing in companies in the United States.
The investment process is designed to highlight companies that are engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.
The process also focuses on companies that benefit significantly from scientific and technological advances in biotechnology.
Additionally, the research team evaluates a company’s financial condition and industry position, as well as market and economic conditions.
Then the manager constructs a diversified portfolio of stocks from a list of companies in the benchmark index favored by the research team and allocates capital based on its conviction level.
The fund has the flexibility to invest in domestic and foreign issuers.
The fund seeks capital appreciation by investing in companies in the United States.
The investment process is designed to highlight companies that are engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.
The process also focuses on companies that benefit significantly from scientific and technological advances in biotechnology.
Additionally, the research team evaluates a company’s financial condition and industry position, as well as market and economic conditions.
Then the manager constructs a diversified portfolio of stocks from a list of companies in the benchmark index favored by the research team and allocates capital based on its conviction level.
The fund has the flexibility to invest in domestic and foreign issuers.
The fund seeks capital appreciation by investing in companies in the United States.
The investment process is designed to highlight companies that are engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.
The process also focuses on companies that benefit significantly from scientific and technological advances in biotechnology.
The strategy seeks to outperform its benchmark index through active management.
Then the research team evaluates a company’s free cash flow and the probability risk-adjusted net present value of future earnings, the standard valuation method in the drug-development industry.
In addition, the team assesses a company's drug pipeline, the size of its market opportunity and its relative valuation.
Next, the research team evaluates a company’s financial condition and industry position, as well as market and economic conditions.
Then the manager constructs a diversified portfolio of stocks from a list of companies in the benchmark index favored by the research team and allocates capital based on its conviction level.
The manager focuses around four major themes such as long-term winners with superior product pipelines, turnaround situations, breakthrough innovations and early-stage firms with promising science.
The fund has the flexibility to invest in domestic and foreign issuers.
